Acasti Pharma Reports First Quarter 2023 Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Acasti Pharma (ACST) Reports Q2 Loss of $0.10
August 11, 2022 7:10 AM EDTAcasti Pharma (NASDAQ: ACST) reported Q2 EPS of ($0.10).
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
... More